Navigation Links
ProGenTech Completes $21 Million Series C Financing
Date:4/2/2008

EMERYVILLE, Calif., April 2, 2008 /PRNewswire/ -- ProGenTech, a life sciences company based in Shanghai, China and Emeryville, CA developing a contamination free, cassette based automated nucleic acid purification system, announced today that it has closed a $21 million Series C financing led by Bay City Capital (San Francisco) and DT Capital (Shanghai).

"We are very impressed by the technical achievements the ProGenTech team has accomplished to date. This round of financing gives us a unique opportunity to integrate the value of the enhanced ProGenTech management team, Bay City Capital's life sciences expertise and DT Capital's local know-how. We are excited to work with ProGenTech in establishing itself as a key player in its field," said Joe Tian, Founding Managing Partner at DT Capital.

The key advantage of ProGenTech's automated system is that it eliminates the possibilities of user exposure and cross-contamination by virtue of its unique cassette-based approach. The company's initial products have applications in both research and medical diagnostics.

ProGenTech was founded by Steve Yu and Jesus Ching, engineers with extensive experience in biotechnology instrumentation companies. Steve Yu will remain a director of the company and become its President and COO. Jesus Ching will become the Chief Scientific Officer of ProGenTech. Previous funding was obtained from angel investors, led by David Hu, who remains a director of the company. The investment by Bay City Capital and DT Capital is the company's first round of institutional venture capital.

In connection with this financing, ProGenTech also announced that Trevor Hawkins, PhD has joined the company as Chairman and Chief Executive Officer. Dr. Hawkins is the primary inventor of the magnetic bead technology used by several commercial biotechnology companies. Dr. Hawkins was previously the CEO of Philips Molecular Healthcare business and held senior executive roles at GE and M
'/>"/>

SOURCE ProGenTech, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...., Nov. 27 GSI Group Inc...of precision technology products and semiconductor...f the Company,s shareholders has been scheduled fo...f the meeting will be announced in due course. As...isition notice from Stephen Bershad, a holder of g...
(Date:11/27/2009)...Biotech firm Replikins Ltd. today issued its lates...ata. It shows that the lethality of the virus has...e virus,s current outbreak in the spring of 2009 t...d. 0.1). The H1N1 infectivity count, however, rema...PRWEB) November 27, 2009 -- Biotech firm Replikins...
(Date:11/27/2009)...Nov. 27 The Gymboree Cor...bert, CFO/COO, will present at the NASDAQ OMX 23rd...air Hotel in London, England, on Wednesday, Decemb...a live broadcast of The Gymboree Corporation,s pre...gymboree.com, click on "Our Company" at the bottom...
(Date:11/27/2009)...SEINE, France, Nov. 27 Team Garmin...ng team dedicated to ethical sporting and developi...nced today that it will become Team Garmin-Transit... new sponsor of the team. Transitions Optical is t...r, offering the most advanced photochromic technol...
(Date:11/27/2009)...XenaCare Holdings has announced that it has become...ne of the largest nonprofit organizations dedicate...n. , Delray Beach, FL (Vo...(OTCBB: XCHO), a company specializing in the marke...e products, has announced today that is has become...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
...esenting cutting-edge research in basic, clinical,...ng chair Steven M. Dubinett, M.D., director of the...Comprehensive Cancer Center. "As the only comprehe...discoveries." , The 2008 program will cover a wid...
...s to Eat Right, Move More ... last decade can be defined by,the ups and downs o...ut of,fashion like shoulder pads and hemlines. Yet... campaign crossing the country, the Campaign for H...
... Strategic Use of Mergers ...The Deal,( http://www.thedeal.com ) magazine has n...care sector winner of its inaugural,Most Admired C...ott has reshaped its business portfolio with a,foc...
...or its 296 Percent Revenue ...ide, a global health and,safety services company, ...tte,s 2008 Technology Fast 500, a ranking of the 5... revenue growth,over five years, from 2003-2007. H...
...nce Prevention, SAN FRANCISCO, Nov. 12 Kismet Ev...on, and homelessness inspires her to provide,suppo...do Ramos brings the,power of education and his per...ions become more effective in,preventing violence....
...en found that identifies rare adult liver stem cel...ue has the potential for cell-replacement therapy.... of Pennsylvania School of Medicine led by Linda G...e into both liver cells and cells that line the bi...
Other Medicine News:Health News:AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research 2Health News:Message to Philadelphia Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Philadelphia Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers 2Health News:Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers 3Health News:HTH Worldwide Ranked Number 435 Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500 2Health News:HTH Worldwide Ranked Number 435 Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500 3Health News:Three Community Leaders to Receive Foundation's 2008 California Peace Prize 2Health News:Three Community Leaders to Receive Foundation's 2008 California Peace Prize 3Health News:Stem cells with potential to regenerate injured liver tissue identified by Penn researchers 2
(Date:11/25/2009)..., CANOGA PARK, Calif., Nov. 25 ...lace rankings in the American Academy of Family Ph...2009 EHR User Satisfaction Survey for improving me...agement, all critical for new ARRA Stimulus legisl...ing their EMR had a positive effect in determining...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-FirstCal...r. Michael J. McKelvey, the Company,s President an...Vice President and CFO, are scheduled to present a...ence at 1:30 PM EST on December 1, 2009 in New Yor...ess the presentation by visiting the Company,s cor...
(Date:11/25/2009)..., COLLEGE PARK, Md., Nov. 25 /PRNewswire-USNews...eloping a shaving cream-like foam that stops sever...t Promising Security Idea category of the Global S... today. ,, Selected from more than 100 entries ...ir invention at the GSC Security Summit conference...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 1Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 2Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 3Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 4Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 5Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 6Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 7Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 8Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 9Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 10New Test Assesses Individual Breast Cancer Risk 58896 1New Test Assesses Individual Breast Cancer Risk 58896 2New Test Assesses Individual Breast Cancer Risk 58896 3SAGE launches Genes 26amp 3B Cancer 58891 1SAGE launches Genes 26amp 3B Cancer 58891 2
HT-PB
CapSure Novus
Brilliant S+
RZ Series
Medicine Products: